l-3,4-dihydroxyphenylalanine (l-DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha-synuclein mouse models of Parkinson's disease.
J Neurochem
; 150(1): 88-106, 2019 07.
Article
in En
| MEDLINE
| ID: mdl-30716176
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Parkinson Disease
/
Brain
/
Levodopa
/
Oxidative Stress
/
Antiparkinson Agents
Limits:
Animals
/
Humans
Language:
En
Journal:
J Neurochem
Year:
2019
Document type:
Article
Affiliation country:
Australia